Jiangsu Recbio Technology Income Statement

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Revenue	12.73	-	-	-	-
Other Revenue	-	27.01	30.38	5.33	6.2
Revenue	12.73	27.01	30.38	5.33	6.2
Revenue Growth (YoY)	-52.88%	-11.10%	470.46%	-14.10%	325.17%
Cost of Revenue	1.49	11.06	8.04	-	-
Gross Profit	11.23	15.95	22.34	5.33	6.2
Selling, General & Admin	92.95	111.67	152.24	163.96	146.51
Research & Development	520.7	476.12	487.85	716.44	472.95
Operating Expenses	613.65	587.79	640.09	880.4	619.46
Operating Income	-602.41	-571.85	-617.75	-875.08	-613.26
Interest Expense	-23.96	-18.9	-13.57	-3.53	-56.31
Interest & Investment Income	-	21.38	45.58	23.98	10.36
Currency Exchange Gain (Loss)	-	8.97	17.5	115.06	-8.49
Other Non Operating Income (Expenses)	18.14	2.29	-2.12	0.02	-1.06
EBT Excluding Unusual Items	-608.23	-558.1	-570.36	-739.55	-668.76
Gain (Loss) on Sale of Investments	-	-	-	3.56	11.22
Gain (Loss) on Sale of Assets	-	0.06	6.61	-	-0.02
Asset Writedown	-	-3.86	-8.69	-	-
Pretax Income	-608.23	-561.9	-572.44	-736	-657.57
Income Tax Expense	2.16	-	-	-	-
Earnings From Continuing Operations	-610.39	-561.9	-572.44	-736	-657.57
Minority Interest in Earnings	-	-0.49	0.49	13.29	0.01
Net Income	-610.39	-562.39	-571.96	-722.7	-657.56
Preferred Dividends & Other Adjustments	-	-4.93	-	-	-
Net Income to Common	-610.39	-557.46	-571.96	-722.7	-657.56
Shares Outstanding (Basic)	531	479	481	474	421
Shares Outstanding (Diluted)	531	479	481	474	421
Shares Change (YoY)	10.91%	-0.50%	1.42%	12.52%	36.60%
EPS (Basic)	-1.15	-1.16	-1.19	-1.52	-1.56
EPS (Diluted)	-1.15	-1.16	-1.19	-1.52	-1.56
Free Cash Flow	-	-636.66	-850.11	-876.27	-710.79
Free Cash Flow Per Share	-	-1.33	-1.77	-1.85	-1.69
Gross Margin	88.28%	59.05%	73.54%	100.00%	100.00%
Operating Margin	-4733.73%	-2117.56%	-2033.60%	-16433.33%	-9892.89%
Profit Margin	-4796.40%	-2064.30%	-1882.86%	-13571.89%	-10607.53%
Free Cash Flow Margin	-	-2357.56%	-2798.55%	-16455.78%	-11466.17%
EBITDA	-531.62	-501.05	-569.87	-847.67	-598.36
D&A For EBITDA	70.79	70.79	47.88	27.41	14.9
EBIT	-602.41	-571.85	-617.75	-875.08	-613.26

Source: S&P Global Market Intelligence. Standard template. Financial Sources.